文献速递肿瘤 PET/CT

Q.Clear重建算法对淋巴瘤PET/CT图像判读的影响

Impact of the Q.Clear reconstruction algorithm on the interpretation of PET/CT images in patients with lymphoma.
PubMed 文献 · EJNMMI Res · 2020-08-26

本研究对280例淋巴瘤患者的18F-FDG PET/CT扫描分别用Q.Clear与OSEM重建并比较。两种算法在分期和复发怀疑时判读一致,但在早期和终末疗效评估中Deauville评分出现不一致,Q.Clear使部分阴性转为阳性。作者建议疗效评估仍采用标准OSEM重建。

要点

  • Q.Clear使88.8%扫描的靶病灶SUVmax高于OSEM。
  • 早期和终末疗效评估中Q.Clear可致Deauville评分不一致。
  • 作者推荐疗效评估使用标准OSEM重建。

核心结论

  • Q.Clear算法仅在小部分淋巴瘤患者中改变PET/CT判读,但作者推荐疗效评估使用标准OSEM重建。

研究设计与样本

  • 回顾性分析280例淋巴瘤患者的18F-FDG PET/CT扫描,分别用Q.Clear和OSEM重建并比较。

主要发现

  • 分期扫描中69/70例两种算法诊断一致。
  • 早期疗效评估70例中11例(15.7%)Deauville评分不一致(p < 0.001)。
  • 终末疗效评估70例中11例Deauville评分不一致。
  • Q.Clear使早期疗效评估3例(4.3%)、终末疗效评估7例(10.0%)由阴性转为阳性。
  • 复发怀疑扫描70例结果全部一致;88.8%扫描中Q.Clear的SUVmax高于OSEM。

关键数值与推荐

  • Deauville评分不一致在早期疗效评估中p < 0.001。
  • Q.Clear致阴性转阳性:早期疗效评估3/70例(4.3%),终末疗效评估7/70例(10.0%)。
  • SUVmax在88.8%扫描中Q.Clear高于OSEM。

临床怎么用

  • 淋巴瘤疗效评估(尤其早期和终末)应使用标准OSEM重建以保持判读一致性。
  • 若使用Q.Clear重建,需注意其可能提高SUVmax并导致Deauville评分升级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Q.Clear is a new Bayesian penalized-likelihood PET reconstruction algorithm. It has been documented that Q.Clear increases the SUVmax values of different malignant lesions. PURPOSE: SUVmax values are crucial for the interpretation of PET/CT images in patients with lymphoma, particularly when the early and final responses to treatment are evaluated. The aim of the study was to systematically analyse the impact of the use of Q.Clear on the interpretation of PET/CT in patients with lymphoma. METHODS: A total of 280 18F-FDG PET/CT scans in patients with lymphoma were performed for staging (sPET), for early treatment response (iPET), after the end of treatment (ePET) and when a relapse of lymphoma was suspected (rPET). Scans were separately reconstructed with two algorithms, Q.Clear and OSEM, and further compared. RESULTS: The stage of lymphoma was concordantly diagnosed in 69/70 patients with both algorithms on sPET. Discordant assessment of the Deauville score (p < 0.001) was found in 11 cases (15.7%) of 70 iPET scans and in 11 cases of 70 ePET scans. An upgrade from a negative to a positive scan by Q.Clear occurred in 3 cases (4.3%) of iPET scans and 7 cases (10.0%) of ePET scans. The results of all 70 rPET scans were concordant. The SUVmax values of the target lymphoma lesions measured with Q.Clear were higher than those measured with OSEM in 88.8% of scans. CONCLUSION: Although the Q.Clear algorithm may alter the interpretations of PET/CT in only a small proportion of patients, we recommend using standard OSEM reconstruction for the assessment of treatment response.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Wyrzykowski M, Siminiak N, Kaźmierczak M, et al. Impact of the Q.Clear reconstruction algorithm on the interpretation of PET/CT images in patients with lymphoma. EJNMMI Res. 2020. PMID: 32845406. doi:10.1186/s13550-020-00690-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。